Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma
2013
Background
Protein tyrosine kinase 6 (PTK6), also known as breast tumor kinase (Brk), was a nonreceptor tyrosine kinase containing SH3, SH2, and tyrosine kinase catalytic domains. The deregulated expression of PTK6 was observed in various human cancers. However, little was known about PTK6 expression and its clinicopathological significance in human laryngeal squamous cell carcinoma (LSCC).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
29
References
17
Citations
NaN
KQI